Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.405 USD | +2.95% | +2.26% | -30.42% |
Jun. 05 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.42% | 140M | |
+47.27% | 56.87B | |
+38.59% | 39.72B | |
-6.52% | 39.27B | |
-4.42% | 28.73B | |
+14.08% | 26.21B | |
-17.12% | 19.79B | |
+31.97% | 12.28B | |
+28.17% | 12.23B | |
+0.21% | 12.12B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals Names New CEO; to Cut Staff by 35%; Shares Drop